Gilead Sciences stock has room to climb, and investors shouldn’t overlook the company’s impressive record in navigating HIV policy, Citi Research says. Analysts led by Geoff Meacham reiterated a Buy ...

Bay Area drug giant Gilead is plotting the trial of a groundbreaking, once-a-year HIV prevention drug lenacapavir.

Truvada is a brand name for the medications tenofovir disoproxil fumarate and emtricitabine. Doctors prescribe it to reduce as well as prevent viral infections, such as HIV. It can be part of the ...

and the decision paves the way for much cheaper therapies for people who need to take drugs to suppress their infection and prevent it turning into AIDS. But Truvada can also be used for HIV pre ...

House Bill 2769, titled Life or Health Insurances; Unfair Discrimination, Pre-Exposure Prophylaxis for Prevention of HIV, was ...

The company has two drugs for HIV prevention in its portfolio, Descovy and Truvada. Shares of another HIV drugmaker, GSK plc GSK, were also down 2.08% on the news. However, the direct impact of ...

In both trials, twice-yearly lenacapavir also demonstrated superiority of prevention of HIV infections when compared with once-daily oral Truvada® (emtricitabine 200mg and tenofovir disoproxil ...